相关实验视频
Updated: Jul 18, 2026

08:18
A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
肥胖如何导致糖尿病:不是一个的故事
1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6149, USA. lazar@mail.med.upenn.edu
概括
肥胖相关的糖尿病是一个日益严重的危机. 机理学研究显示,脂肪分子和炎症将肥胖与糖尿病联系起来,提供了潜在的治疗点.
科学领域:
- 内分泌学和新陈代谢学
- 分子生物学分子生物学
- 进化医学是一种进化医学.
背景情况:
- 与肥胖相关的糖尿病代表着一个重大的全球健康危机.
- 现代生活方式与丰富的食物和减少的体力活动加剧了这种流行病.
- 了解生物基础对于有效干预至关重要.
研究的目的:
- 探索肥胖相关糖尿病的生物学基础.
- 审查关于肥胖与糖尿病关系的进化和机械学观点.
- 根据机理学发现,确定潜在的治疗点.
主要方法:
- 关于"节"基因的进化理论的审查.
- 对研究分子路径的机械学研究的分析.
- 检查脂肪分子和炎症的作用.
主要成果:
- 进化论理论虽然有趣,但却是推测性的,难以验证.
- 机械学研究已经确定了许多脂肪衍生分子.
- 已经发现了这些分子,炎症和肥胖-糖尿病之间的重要联系.
结论:
- 脂肪分子和炎症的相互作用是肥胖相关糖尿病的关键因素.
- 这些机制性见解为治疗开发提供了有希望的途径.
- 对这些途径的进一步研究可能会为这种广泛的疾病带来新的治疗方法.
相关概念视频
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

